Can These 3 Healthcare Dividend Stocks Deliver Income Growth?

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

Should You Invest $1,000 in Gilead Sciences Right Now?

Before you consider Gilead Sciences, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Gilead Sciences wasn't on the list.

While Gilead Sciences currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Kate Stalter
About The Author

Kate Stalter

Contributing Author

Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Gilead Sciences (GILD)
4.9165 of 5 stars
$125.050.1%2.62%17.04Moderate Buy$158.41
Medtronic (MDT)
4.9297 of 5 stars
$80.691.8%3.52%21.63Moderate Buy$99.00
Pfizer (PFE)
4.2074 of 5 stars
$24.75-1.3%6.95%18.89Hold$28.82
Eli Lilly and Company (LLY)
4.597 of 5 stars
$1,110.370.8%0.62%39.44Moderate Buy$1,230.89
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines